Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00895375 · ClinicalTrials.gov registry record
Prevalence of Sleep Disturbances in Psoriasis
A clinical trial of Psoriasis, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- 64
- Enrollment target
- 1
- Study location
NCT00895375 is a study of Psoriasis that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 64 participants, below the 488-participant average among 125 other Psoriasis trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00895375, a study of Psoriasis, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- 64 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare the sleep quality of patients with psoriasis to patients without psoriasis.
Conditions Studied
Study Locations (1)
North Carolina
- Wake Forest University Health Sciences, Dermatology - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2009-10 |
| Est. Completion | 2014-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00895375
The ClinicalTrials.gov registry entry for NCT00895375 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 488-participant average among 125 other Psoriasis trials with a reported enrollment target (87% lower). The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Psoriasis appearing as the primary indexed condition, and to 0 interventions.
NCT00895375 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT00895375 about?
NCT00895375 is a clinical study titled "Prevalence of Sleep Disturbances in Psoriasis". The purpose of this study is to compare the sleep quality of patients with psoriasis to patients without psoriasis.
What is the current status of trial NCT00895375?
This trial is currently completed. The enrollment target is 64 participants. The study started on 2009-10. Estimated completion is 2014-12.
What conditions does trial NCT00895375 study?
This clinical trial studies the following conditions: Psoriasis.
Who is sponsoring clinical trial NCT00895375?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00895375 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Psoriasis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project
RECRUITING
-
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer
RECRUITING · Phase 1
-
Use of Total-Body PET to Quantify Systemic and Cutaneous Inflammation in Psoriasis Patients Before and After Intervention With a Nutritionally Balanced Diet
RECRUITING · NA
-
Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
RECRUITING
-
Duobrii in Combination With Biologics
RECRUITING · Phase 4
-
Metabolic Profiling of Immune Responses in Immune-mediated Diseases
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.